A Study to Learn How Different Forms of The Study Medicine Called Phenytoin Are Taken up Into the Blood in Healthy Adults
NCT06466473 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 35
Last updated 2024-10-08
Summary
The purpose of this study is to understand how the different formulation of phenytoin is taken up into the blood in Healthy Adults.
This study is seeking healthy adult participants. All the study participants will receive Phenytoin 50 mg chewable tablets manufactured at Ascoli and Vega Baja manufacturing site.
We will measure how the phenytoin will be taken up into the blood in Healthy Adults following oral dosing of Phenytoin.
This will help us determine if the Phenytoin 50 mg chewable tablets manufactured at Ascoli and Vega Baja manufacturing site are similar or not.
Conditions
- Healthy
Interventions
- DRUG
-
Phenytoin (Ascoli)
Phenytoin 50mg chewable tablets
- DRUG
-
Phenytoin (Vega Baja)
Phenytoin 50mg chewable tablets
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Pfizer CT.gov Call Center · Pfizer
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-07-03
- Primary Completion
- 2024-10-04
- Completion
- 2024-10-04
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
A Study to Learn How Various Tablets of the Study Medicine Vepdegestrant Are Taken up Into the Blood of Healthy Adults
NCT06347861 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability of BI 207127 Trial Formulation II Prototypes Versus BI 207127 Trial Formulation I in Healthy Volunteers
NCT02182414 ·Status: COMPLETED ·Phase: PHASE1
-
Divalproex Sodium Delayed-Release Tablets Under Fasting Conditions
NCT00834639 ·Status: COMPLETED ·Phase: PHASE1
-
Divalproex Sodium 500 mg Extended Release Tablets Under Non-Fasting Conditions
NCT00974012 ·Status: COMPLETED ·Phase: PHASE1
-
Single Dose Crossover Comparative Bioavailability Study of Eslicarbazepine Acetate Versus To-be-marketed Formulation
NCT02283840 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study of Divalproex Sodium 125 MG Delayed Release Tablets Under Fasting Conditions
NCT00864006 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability and Food Effect of Sodium Valproate Minitablets in Healthy Subjects.
NCT06211283 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 11634 Solution in Healthy Male Volunteers
NCT02214914 ·Status: COMPLETED ·Phase: PHASE1
-
Divalproex Sodium Delayed-Release Tablets Under Non-Fasting Conditions
NCT00834990 ·Status: COMPLETED ·Phase: PHASE1
-
A Crossover Study to Evaluate Pegilodecakin (LY3500518) in Healthy Participants
NCT04194892 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of RTA 901 in Healthy Adults
NCT02666963 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Understand the Effects of Carbamazepine on How Vepdegestrant is Processed in Healthy Participants
NCT06005688 ·Status: COMPLETED ·Phase: PHASE1
-
Study of the Blood Concentrations of Two Formulations of REGN1033 in Healthy Subjects
NCT02741739 ·Status: COMPLETED ·Phase: PHASE1
-
To Assess Safety, Tolerability and Pharmacokinetics of BI 416970 in Healthy Male Volunteers
NCT02093819 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 113823 Powder in Bottle (PiB) and Tablet in Healthy Male Volunteers
NCT02259972 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Effect of Formulation and Food on Calderasib (MK-1084) in Healthy Adult Participants (MK-1084-011)
NCT06942741 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Learn How a Tablet Compared With an IV Infusion of the Study Medicine Called Vepdegestrant is Taken up Into the Blood in Healthy Adults
NCT06911788 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic Comparability Study in Healthy Participants - PF-06881894 On-Body Injector Relative to Prefilled Syringe
NCT05194579 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Determine the Effect of the Timing of a Meal on the Pharmacokinetics of Entinostat
NCT02922946 ·Status: COMPLETED ·Phase: PHASE1
-
PK and Safety Study of BIIB074 in Healthy Japanese and Caucasian Participants
NCT02831517 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence of IVAX Warfarin Tablets and Coumadin Brand Warfarin Tablets in Healthy Volunteers
NCT02171494 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men and Women to Test How BI 3000202 is Taken up and Processed by the Body
NCT07273474 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of RO6889678 and the Combination of RO6889678 With Ritonavir in Healthy Participants
NCT02321384 ·Status: TERMINATED ·Phase: PHASE1
-
Relative Bioavailability BI 10773 and Metformin in Healthy Male Volunteers
NCT02172248 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability Study in Healthy Subjects Comparing 2 Dry Powder Oral Suspensions of Rivaroxaban Under Fasting and 20 mg of an Oral Suspension of Rivaroxaban Under Fed Conditions to 10 mg of an Immediate Release Tablet Under Fasting Conditions
NCT02367027 ·Status: COMPLETED ·Phase: PHASE1